Epidemiology, risk factors for and outcome of candidaemia among non-neutropenic patients in a Greek intensive care unit

Mycoses

Volumn 54, Issue 2, 2011, Pages 154-161

  Pratikaki, Maria ^a,b   Platsouka, Evangelia ^b   Sotiropoulou, Christina ^a   Douka, Evangelia ^a   Paramythiotou, Elizabeth ^a   Kaltsas, Panagiotis ^a   Kotanidou, Anastasia ^a   Paniara, Olga ^b   Roussos, Charis ^a   Routsi, Christina ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b EVANGELISMOS HOSPITAL   (Greece)

Author keywords

Candida; Candidaemia; Critically ill patients; Illness severity; Intensive care unit; Risk factors

Indexed keywords

ALBUMIN; AMINOGLYCOSIDE; AMPHOTERICIN B; ANTIFUNGAL AGENT; BETA LACTAM; CARBAPENEM; CEPHALOSPORIN; COLISTIN; FLUCONAZOLE; FLUCYTOSINE; GLYCOPEPTIDE; ITRACONAZOLE; METRONIDAZOLE; OXAZOLIDINONE DERIVATIVE; QUINOLONE; VORICONAZOLE;

ADULT RESPIRATORY DISTRESS SYNDROME; ALBUMIN BLOOD LEVEL; APACHE; ARTICLE; CANDIDA; CANDIDEMIA; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; CANDIDEMIA; CASE-CONTROL STUDIES; CRITICAL ILLNESS; CROSS INFECTION; FEMALE; GREECE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

CANDIDA;

EID: 79951587577     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2009.01787.x     Document Type: Article

References (34)

1. Beck-Sague C, Jarvis WR. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. J Infect Dis 1993; 167: 1247-51.
2. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24, 179 cases from a retrospective nationwide surveillance study. Clin Infect Dis 2004; 39: 309-17.
3. Bassetti M, Right E, Costa A et al. Epidemiological trends in nosocomial candidemia in intensive care. BMC Infectious Dis 2006; 6: 21. doi: DOI: 10.1186/1471-2334-6-21
4. Blumberg HM, Jarvis WR, Soucie JM et al. Risk factors for Candida bloodstream infections in surgical intensive care unit patients: The NEMIS prospective multicenter study. Clin Infect Dis 2001; 33: 177-86.
5. Ostrosky-Zeichner L, Pappas PG. Invasive candidiasis in the intensive care unit. Crit Care Med 2006; 34: 857-63.
6. Eggiman P, Garbino G, Pittet D. Epidemiology of Candida species infections in critically ill non-immunosupressed patients. Lancet Infect Dis 2003; 3: 685-702.
7. Amrutkar PP, Rege MD, Chen H, LaRocco MT, Gentry LO, Garey KW. Comparison of risk factors for candidemia versus bacteremia in hospitalized patients. Infection 2006; 34: 322-7.
8. Luzzati R, Allegranzi B, Antozzi L et al. Secular trends in nosocomial candidemia in non-neutropenic patients in an Italian tertiary hospital. Clin Microbiol Infect 2005; 11: 908-13.
9. Puzniak L, Teutsch S, Powderly W, Polish L. Has the epidemiology of nosocomial candidemia changed? Infect Control Hosp Epidemiol 2004; 25: 628-33.
10. Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 1999; 29: 239-44.
11. Blot SI, Vandewoude KH, Hoste EA, Colardyn FA. Effects of nosocomial candidemia on outcomes of critically ill patients. Am J Med 2002; 113: 480-5.
12. Leleu G, Aegerter P, Guidet B, for College des Utilisateurs de Base de Donnees en Reanimation. Systemic candidiasis in intensive care units: a multicenter, matched-cohort study. J Crit Care 2002; 17: 168-75.
13. Michalopoulos AS, Geroulanos S, Mentzelopoulos SD. Determinants of candidemia and candidemia-related death in cardiothoracic ICU patients. Chest 2003; 124: 2244-55.
14. Knauss WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818-29.
15. Vincent JL, De Mendoka A, Cantraine F et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units. Results of a multicenter, prospective study. Crit Care Med 1998; 26: 1793-800.
16. Levy MM, Fink MP, Marshall JC et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 2003; 29: 530-8.
17. Gudlaugsson O, Gillespie S, Lee K et al. Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis 2003; 37: 1172-7.
18. Clinical Laboratory Standards Institute. Reference Method for Both Dilution Antifungal Susceptibility Testing of Yeasts. Approved Standard, 3rd edn. CLSI document M27-A3. Wayne, PA: CLSI, 2008.
19. Ostrosky-Zeichner L, Sable C, Sobel J et al. Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis 2007; 26: 271-6.
20. Voss A, le Noble JL, Verduyn LF, Foudraine NA, Meis JF. Candidemia in intensive care unit patients: risk factors for mortality. Infection 1997; 25: 8-11.
21. Peres-Bota D, Rodriguez-Villalobos H, Dimopoulos G, Melot C, Vincent JL. Potential risk factors for infection with Candida spp. in critically ill patients. Clin Microbiol Infect 2004; 10: 550-5.
22. Nolla-Salas J, Sitges-Serra A, Leon-Gil C et al. Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Intensive Care Med 1997; 23: 23-30.
23. Bougnoux ME, Kac G, Aegerter P, D'Enfert C, Fagon JY, the CandiRea Study Group. Candidemia and candiduria in critically ill patients admitted to intensive care units in France: incidence, molecular diversity, management and outcome. Intensive Care Med 2008; 34: 292-9.
24. Wisplinghoff H, Seifert H, Wenzel RP, Edmond MB. Inflammatory response and clinical course of adult patients with nosocomial bloodstream infections caused by Candida spp. Clin Microbiol Infect 2006; 12: 170-7.
25. Guery BP, Arendrup MC, Auzinger G et al. Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis. Intensive Care Med 2009; 35: 55-62.
26. Mean M, Marchetti O, Calandra T. Bench-to-bedside review: Candida infections in the intensive care unit. Crit Care 2008; 12: 204.
27. KcKinnon PS, Goff DA, Kern JW et al. Temporal assessment of Candida risk factors in the surgical intensive care unit. Arch Surg 2001; 136: 1401-9.
28. Wenzel RP, Gennings C. Bloodstream infections due to Candida species in the intensive care unit: indentifying especially high risk patients to determine prevention strategies. Clin Infect Dis 2005; 41(Suppl. 6): S389-93.
29. Lin MY, Carmeli Y, Zumsteg J et al. Prior antimicrobial therapy and risk for hospital acquired Candida glabrata and Candida Kruzei fungemia: a case-case-control study. Antimicrob Agents Chemother 2005; 49: 4555-60.
30. Jorda-Markos R, Alvarez-Lerma F, Jurado M et al. Risk factors for candidaemia in critically ill patients: a prospective surveillance study. Mycoses 2007; 50: 302-10.
31. Vincent JL, Anaissie E, Bruining H et al. Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care. Intensive Care Med 1998; 24: 206-16.
32. Falagas ME, Apostolou KE, Pappas VD. Attributable mortality of candidemia: a systematic review of matched cohort and case-control studies. Eur J Clin Microbiol Infect Dis 2006; 25: 419-25.
33. Weinberger M, Leibovici L, Perez S et al. Characteristics of candidemia with Candida-albicans compared with non-albicans Candida species and predictors of mortality. J Hosp Infect 2005; 61: 146-54.
34. Tortorano AM, Peman J, Bernhardt H et al. Epidemiology of candidemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis 2004; 23: 317-22.